Industries - Autoimmune Disease Diagnostics Market Analysis by Product (Consumables, Assay Kits, Instruments), by Test Type (Inflammatory Markers, Routine Laboratory Tests), by Disease Type (Localized, Systemic Autoimmune Diseases), and by Region – Forecast to 2025

Ablation Technology Market Analysis

Autoimmune Disease Diagnostics Market Analysis by Product (Consumables, Assay Kits, Instruments), by Test Type (Inflammatory Markers, Routine Laboratory Tests), by Disease Type (Localized, Systemic Autoimmune Diseases), and by Region – Forecast to 2025
October 2020

SKU: N/A Category:
Clear
  • Description
  • Additional information
  • Enquire about

Description

Autoimmune Disease Diagnostics Market Analysis by Product (Consumables, Assay Kits, Instruments), by Test Type (Inflammatory Markers, Routine Laboratory Tests), by Disease Type (Localized, Systemic Autoimmune Diseases), and by Region - Forecast to 2025

Published: October 2020 | Historical Data: 2017-2019 | Base Year: 2019
SKU: ICI-HC-1028 | Number of Pages: 142 | Category: Clinical Diagnostics

The global autoimmune disease diagnostics market size is estimated to be USD 4,063.6 million in 2019 and is expected to witness a CAGR of 8.1% during the forecast period. Increasing prevalence of various autoimmune disorders, growing healthcare awareness, rising government expenditure, availability of advanced technologies, and focus on R&D by leading companies are some of the major factors that boosts the market growth. Technological advances and rise in lab automation will also propel the market growth. However, the stringent government regulations and a high capital requirement for the manufacturing of these products are hindering the market growth.

Autoimmune Disease Diagnostics Market

By Product

Based on product, the market is segmented into consumables, assay kits, and instruments. Consumables segment accounted for the highest revenue share in 2019. The instrument segment is projected to grow at a lucrative CAGR during the forecast period. This is attributed to the rising prevalence of autoimmune diseases and product advancements by market players.

By Test Type

Based on test type, the market is categorized into routine laboratory tests, inflammatory markers, autoantibodies & immunologic tests, and others. Routine laboratory tests segment is expected to grow at a fastest CAGR during the forecast period. This is due to the developing diagnostics infrastructure and rising number of autoimmune disorders globally.

By Disease Type

Based on disease type, the market is divided into localized and systemic autoimmune diseases. The localized disease segment dominated the market in 2019 due to the high level of awareness among the patients. However, the systemic diseases segment is projected to grow at the fastest CAGR during the forecast period due to the government initiatives to cover patients under this category, development of novel drugs for treatment, and rising awareness for systemic autoimmune diseases in developing countries.

Regional Insights

In 2019, North America accounted for the highest revenue share in the global autoimmune disease diagnostics market and is projected to maintain its position during the forecast period. This is attributed to well-developed healthcare infrastructure, growing prevalence of autoimmune diseases, and presence of leading players in this region. Asia Pacific is estimated to exhibit the fastest CAGR over the forecast period owing to the high level of unmet medical needs, developing healthcare infrastructure, and a gradual increase in patient awareness in this region.

North America Autoimmune Disease Diagnostics Market Size (2017-2025), USD Million

North America Autoimmune Disease Diagnostics Market

Competitor Insights

Some of the key players in the market are F. Hoffmann-La Roche Ltd. (Switzerland); Abbott Laboratories (US); Beckman Coulter (US); Siemens Healthineers (Germany); SQI Diagnostics (Canada); Thermo Fisher Scientific, Inc. (US); Seramun Diagnostica GmbH (Germany); Trinity Biotech (Ireland); Grifols (Spain); Oncimmune (UK); Bio-Rad Laboratories (US); Werfen (Spain); HTG Molecular Diagnostics (US); Exagen Inc. (US); AESKU GROUP GMBH & CO. KG (Germany); ORGENTEC Diagnostika (Germany); Cambridge Life Sciences Limited (UK); KRONUS (US); and A. Menarini Diagnostics s.r.l (Italy). The leading players operating in the industry are adopting various strategies including novel product development, mergers & acquisitions, collaborations, and investment in R&D to sustain their leadership position in the market.

 

This exhaustive research report focuses on market size and forecast at global, segmental, regional and country level along with key market trends and dynamics from 2017 to 2025. The autoimmune disease diagnostics market report is categorized into the following segments and subsegments:

Autoimmune Disease Diagnostics Market, By Product (Revenue, USD Million, 2017 – 2025)

  • Consumables
  • Assay Kits
  • Instruments

Autoimmune Disease Diagnostics Market, By Test Type (Revenue, USD Million, 2017 – 2025)

  • Routine Laboratory Tests
  • Inflammatory Markers
  • Autoantibodies & Immunologic Test
  • Other Tests

Autoimmune Disease Diagnostics Market, By Disease Type (Revenue, USD Million, 2017 – 2025)

  • Systemic autoimmune diseases
    • Rheumatoid arthritis
    • Ankylosing spondylitis
    • Systemic lupus erythematosus (SLE)
    • Others
  • Localized autoimmune diseases
    • Multiple sclerosis
    • Type 1 diabetes
    • Hashimoto’s thyroiditis
    • Idiopathic thrombocytopenic purpura
    • Others

Autoimmune Disease Diagnostics Market, By Region (Revenue, USD Million, 2017 – 2025)

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • Australia
    • South Korea
    • India
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of LATAM
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Rest of MEA

Scope of Autoimmune Disease Diagnostics Market Report:

Key Parameters Details
Data Availability 2017-2025
Historical Years 2017-2019
Base Year Considered 2019
Forecast Period 2019-2025
Company Profiles 15
Companies Considered(Across Value Chain) >50
Value Units Value in USD and CAGR in %
Market Segments Product, Test Type, and Disease Type
Regional Coverage North America (U.S. and Canada), Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe), Asia Pacific (China, Japan, Australia, India, South Korea, Rest of Asia Pacific), Latin America (Brazil, Mexico, Argentina, Rest of LATAM), and the Middle East & Africa (South Africa, Saudi Arabia, Rest of MEA)
Key Market Players F. Hoffmann-La Roche Ltd. (Switzerland); Abbott Laboratories (US); Beckman Coulter (US); Siemens Healthineers (Germany); SQI Diagnostics (Canada); Thermo Fisher Scientific, Inc. (US); Seramun Diagnostica GmbH (Germany); Trinity Biotech (Ireland); Grifols (Spain); Oncimmune (UK); Bio-Rad Laboratories (US); Werfen (Spain); HTG Molecular Diagnostics (US); Exagen Inc. (US); AESKU GROUP GMBH & CO. KG (Germany); ORGENTEC Diagnostika (Germany); Cambridge Life Sciences Limited (UK); KRONUS (US); and A. Menarini Diagnostics s.r.l (Italy)
Custom Analysis Customization up to 60 analyst hours

Autoimmune Disease Diagnostics Market, By Product (Revenue, USD Million, 2017 – 2025)

  • Consumables
  • Assay Kits
  • Instruments

Autoimmune Disease Diagnostics Market, By Test Type (Revenue, USD Million, 2017 – 2025)

  • Routine Laboratory Tests
  • Inflammatory Markers
  • Autoantibodies & Immunologic Test
  • Other Tests

Autoimmune Disease Diagnostics Market, By Disease Type (Revenue, USD Million, 2017 – 2025)

  • Systemic autoimmune diseases
    • Rheumatoid arthritis
    • Ankylosing spondylitis
    • Systemic lupus erythematosus (SLE)
    • Others
  • Localized autoimmune diseases
    • Multiple sclerosis
    • Type 1 diabetes
    • Hashimoto’s thyroiditis
    • Idiopathic thrombocytopenic purpura
    • Others

Autoimmune Disease Diagnostics Market, By Region (Revenue, USD Million, 2017 – 2025)

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • Australia
    • South Korea
    • India
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of LATAM
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Rest of MEA
1. Research Methodology
 1.1. Research Objective
 1.2. Study Scope: Market Segments
 1.3. Study Timeframe, Limitations & Currency
 1.4. Domain-Assisted Cognition (DAC) Framework
  1.4.1. Three-stage Research Methodology
   1.4.1.1. Understand Ecosystem
    1.4.1.1.1. Secondary Research
    1.4.1.1.2. Primary Research
    1.4.1.1.3. Internal Repository
   1.4.1.2. Synthesize Information
    1.4.1.2.1. Data Analysis
    1.4.1.2.2. Data Triangulation
   1.4.1.3. Predict/Project Growth
    1.4.1.3.1. Market Size Estimation
     1.4.1.3.1.1. Bottom-up Approach
     1.4.1.3.1.2. Top-down Approach
    1.4.1.3.2. Data Validation
  1.4.2. Two-stage Quality Check Mechanism
   1.4.2.1. Inspection & Reporting
   1.4.2.2. Quality Audit
2. Market Summary
 2.1. Market Definition & Market Landscape
 2.2. Market Segment Snapshot
 2.3. Geographic Market Snapshot
3. Market Dynamics
 3.1. Market Driver Analysis
  3.1.1. Growing R&D in autoimmune disease treatment
  3.1.2. Rising cases and occurrence of autoimmune diseases
  3.1.3. Increasing expenditure on healthcare and related services
  3.1.4. Growing government initiatives for creating awareness for autoimmune diseases
 3.2. Market Restraint Analysis
  3.2.1. Stringent Regulatory Framework for product quality and research
  3.2.2. Cost burden for Manufacturers and Researchers
 3.3. Market Opportunities
  3.3.1. Product Expansion in Emerging Markets
  3.3.2. Untapped Application of Digital Technology in Autoimmune Disease Diagnosis
  3.3.3. Innovative Product Development with quicker turn around time
4. Industry Outlook
 4.1. Key Market Trends
 4.2. Value Chain Analysis
 4.3. Porter’s 5 Forces Analysis
 4.4. Pricing Analysis (2017-2019)
 4.5. Product Benchmarking
5. Covid-19 Impact and Deviation Analysis
 5.1. Covid-19 Prevalence Analysis
 5.2. Key Market Trends
 5.3. Market Size Deviation Analysis (2020-2025)
6. Autoimmune Disease Diagnostics Market Size and Forecast, by Segments (2017-2025), USD Million
 6.1. Consumables & Assay Kits
 6.2. Instruments
7. Autoimmune Disease Diagnostics Market Size and Forecast, by Disease (2017-2025), USD Million
 7.1. Rheumatoid Arthritis
 7.2. Systemic Lupus Erythematosus
 7.3. Sjögren’s Syndrome
 7.4. Thyroiditis
 7.5. Scleroderma
 7.6. Other Diseases
8. Autoimmune Disease Diagnostics Market Size and Forecast, by Test Type (2017-2025), USD Million
 8.1. Routine Laboratory Tests
 8.2. Inflammatory Markers
 8.3. Autoantibodies & Immunologic Test
 8.4. Other Tests
9. Autoimmune Disease Diagnostics Market Size and Forecast, by End User (2017-2025), USD Million
 9.1. Clinical Laboratories
 9.2. Hospitals
 9.3. Others
10. Autoimmune Disease Diagnostics Market, Regional Analysis (2017-2025), USD Million
 10.1. North America
  10.1.1. Introduction
   10.1.1.1. Market Size & Forecast, by Product (2017-2025), USD Million
   10.1.1.2. Market Size & Forecast, by Disease (2017-2025), USD Million
   10.1.1.3. Market Size & Forecast, by Diagnostic Method (2017-2025), USD Million
   10.1.1.4. Market Size & Forecast, by End-User (2017-2025), USD Million
   10.1.1.5. Market Size & Forecast, by Country (2017-2025), USD Million
  10.1.2. U.S.
   10.1.2.1. Market Size & Forecast, by Product (2017-2025), USD Million
   10.1.2.2. Market Size & Forecast, by Disease (2017-2025), USD Million
   10.1.2.3. Market Size & Forecast, by Diagnostic Method (2017-2025), USD Million
   10.1.2.4. Market Size & Forecast, by End-User (2017-2025), USD Million
  10.1.3. Canada
   10.1.3.1. Market Size & Forecast, by Product (2017-2025), USD Million
   10.1.3.2. Market Size & Forecast, by Disease (2017-2025), USD Million
   10.1.3.3. Market Size & Forecast, by Diagnostic Method (2017-2025), USD Million
   10.1.3.4. Market Size & Forecast, by End-User (2017-2025), USD Million
 10.2. Europe
  10.2.1. Introduction
   10.2.1.1. Market Size & Forecast, by Product (2017-2025), USD Million
   10.2.1.2. Market Size & Forecast, by Disease (2017-2025), USD Million
   10.2.1.3. Market Size & Forecast, by Diagnostic Method (2017-2025), USD Million
   10.2.1.4. Market Size & Forecast, by End-User (2017-2025), USD Million
   10.2.1.5. Market Size & Forecast, by Country (2017-2025), USD Million
  10.2.2. Germany
   10.2.2.1. Market Size & Forecast, by Product (2017-2025), USD Million
   10.2.2.2. Market Size & Forecast, by Disease (2017-2025), USD Million
   10.2.2.3. Market Size & Forecast, by Diagnostic Method (2017-2025), USD Million
   10.2.2.4. Market Size & Forecast, by End-User (2017-2025), USD Million
  10.2.3. UK
   10.2.3.1. Market Size & Forecast, by Product (2017-2025), USD Million
   10.2.3.2. Market Size & Forecast, by Disease (2017-2025), USD Million
   10.2.3.3. Market Size & Forecast, by Diagnostic Method (2017-2025), USD Million
   10.2.3.4. Market Size & Forecast, by End-User (2017-2025), USD Million
  10.2.4. France
   10.2.4.1. Market Size & Forecast, by Product (2017-2025), USD Million
   10.2.4.2. Market Size & Forecast, by Disease (2017-2025), USD Million
   10.2.4.3. Market Size & Forecast, by Diagnostic Method (2017-2025), USD Million
   10.2.4.4. Market Size & Forecast, by End-User (2017-2025), USD Million
  10.2.5. Spain
   10.2.5.1. Market Size & Forecast, by Product (2017-2025), USD Million
   10.2.5.2. Market Size & Forecast, by Disease (2017-2025), USD Million
   10.2.5.3. Market Size & Forecast, by Diagnostic Method (2017-2025), USD Million
   10.2.5.4. Market Size & Forecast, by End-User (2017-2025), USD Million
  10.2.6. Italy
   10.2.6.1. Market Size & Forecast, by Product (2017-2025), USD Million
   10.2.6.2. Market Size & Forecast, by Disease (2017-2025), USD Million
   10.2.6.3. Market Size & Forecast, by Diagnostic Method (2017-2025), USD Million
   10.2.6.4. Market Size & Forecast, by End-User (2017-2025), USD Million
  10.2.7. Russia
   10.2.7.1. Market Size & Forecast, by Product (2017-2025), USD Million
   10.2.7.2. Market Size & Forecast, by Disease (2017-2025), USD Million
   10.2.7.3. Market Size & Forecast, by Diagnostic Method (2017-2025), USD Million
   10.2.7.4. Market Size & Forecast, by End-User (2017-2025), USD Million
  10.2.8. Rest of Europe
   10.2.8.1. Market Size & Forecast, by Product (2017-2025), USD Million
   10.2.8.2. Market Size & Forecast, by Disease (2017-2025), USD Million
   10.2.8.3. Market Size & Forecast, by Diagnostic Method (2017-2025), USD Million
   10.2.8.4. Market Size & Forecast, by End-User (2017-2025), USD Million
 10.3. Asia Pacific (APAC)
  10.3.1. Introduction
   10.3.1.1. Market Size & Forecast, by Product (2017-2025), USD Million
   10.3.1.2. Market Size & Forecast, by Disease (2017-2025), USD Million
   10.3.1.3. Market Size & Forecast, by Diagnostic Method (2017-2025), USD Million
   10.3.1.4. Market Size & Forecast, by End-User (2017-2025), USD Million
   10.3.1.5. Market Size & Forecast, by Country (2017-2025), USD Million
  10.3.2. China
   10.3.2.1. Market Size & Forecast, by Product (2017-2025), USD Million
   10.3.2.2. Market Size & Forecast, by Disease (2017-2025), USD Million
   10.3.2.3. Market Size & Forecast, by Diagnostic Method (2017-2025), USD Million
   10.3.2.4. Market Size & Forecast, by End-User (2017-2025), USD Million
  10.3.3. Japan
   10.3.3.1. Market Size & Forecast, by Product (2017-2025), USD Million
   10.3.3.2. Market Size & Forecast, by Disease (2017-2025), USD Million
   10.3.3.3. Market Size & Forecast, by Diagnostic Method (2017-2025), USD Million
   10.3.3.4. Market Size & Forecast, by End-User (2017-2025), USD Million
  10.3.4. India
   10.3.4.1. Market Size & Forecast, by Product (2017-2025), USD Million
   10.3.4.2. Market Size & Forecast, by Disease (2017-2025), USD Million
   10.3.4.3. Market Size & Forecast, by Diagnostic Method (2017-2025), USD Million
   10.3.4.4. Market Size & Forecast, by End-User (2017-2025), USD Million
  10.3.5. Australia
   10.3.5.1. Market Size & Forecast, by Product (2017-2025), USD Million
   10.3.5.2. Market Size & Forecast, by Disease (2017-2025), USD Million
   10.3.5.3. Market Size & Forecast, by Diagnostic Method (2017-2025), USD Million
   10.3.5.4. Market Size & Forecast, by End-User (2017-2025), USD Million
  10.3.6. South Korea
   10.3.6.1. Market Size & Forecast, by Product (2017-2025), USD Million
   10.3.6.2. Market Size & Forecast, by Disease (2017-2025), USD Million
   10.3.6.3. Market Size & Forecast, by Diagnostic Method (2017-2025), USD Million
   10.3.6.4. Market Size & Forecast, by End-User (2017-2025), USD Million
  10.3.7. Rest of Asia Pacific
   10.3.7.1. Market Size & Forecast, by Product (2017-2025), USD Million
   10.3.7.2. Market Size & Forecast, by Disease (2017-2025), USD Million
   10.3.7.3. Market Size & Forecast, by Diagnostic Method (2017-2025), USD Million
   10.3.7.4. Market Size & Forecast, by End-User (2017-2025), USD Million
 10.4. Latin America (LATAM)
  10.4.1. Introduction
   10.4.1.1. Market Size & Forecast, by Product (2017-2025), USD Million
   10.4.1.2. Market Size & Forecast, by Disease (2017-2025), USD Million
   10.4.1.3. Market Size & Forecast, by Diagnostic Method (2017-2025), USD Million
   10.4.1.4. Market Size & Forecast, by End-User (2017-2025), USD Million
   10.4.1.5. Market Size & Forecast, by Country (2017-2025), USD Million
  10.4.2. Brazil
   10.4.2.1. Market Size & Forecast, by Product (2017-2025), USD Million
   10.4.2.2. Market Size & Forecast, by Disease (2017-2025), USD Million
   10.4.2.3. Market Size & Forecast, by Diagnostic Method (2017-2025), USD Million
   10.4.2.4. Market Size & Forecast, by End-User (2017-2025), USD Million
  10.4.3. Mexico
   10.4.3.1. Market Size & Forecast, by Product (2017-2025), USD Million
   10.4.3.2. Market Size & Forecast, by Disease (2017-2025), USD Million
   10.4.3.3. Market Size & Forecast, by Diagnostic Method (2017-2025), USD Million
   10.4.3.4. Market Size & Forecast, by End-User (2017-2025), USD Million
  10.4.4. Argentina
   10.4.4.1. Market Size & Forecast, by Product (2017-2025), USD Million
   10.4.4.2. Market Size & Forecast, by Disease (2017-2025), USD Million
   10.4.4.3. Market Size & Forecast, by Diagnostic Method (2017-2025), USD Million
   10.4.4.4. Market Size & Forecast, by End-User (2017-2025), USD Million
  10.4.5. Rest of LATAM
   10.4.5.1. Market Size & Forecast, by Product (2017-2025), USD Million
   10.4.5.2. Market Size & Forecast, by Disease (2017-2025), USD Million
   10.4.5.3. Market Size & Forecast, by Diagnostic Method (2017-2025), USD Million
   10.4.5.4. Market Size & Forecast, by End-User (2017-2025), USD Million
 10.5. Middle East & Africa (MEA)
  10.5.1. Introduction
   10.5.1.1. Market Size & Forecast, by Product (2017-2025), USD Million
   10.5.1.2. Market Size & Forecast, by Disease (2017-2025), USD Million
   10.5.1.3. Market Size & Forecast, by Diagnostic Method (2017-2025), USD Million
   10.5.1.4. Market Size & Forecast, by End-User (2017-2025), USD Million
   10.5.1.5. Market Size & Forecast, by Country (2017-2025), USD Million
  10.5.2. South Africa
   10.5.2.1. Market Size & Forecast, by Product (2017-2025), USD Million
   10.5.2.2. Market Size & Forecast, by Disease (2017-2025), USD Million
   10.5.2.3. Market Size & Forecast, by Diagnostic Method (2017-2025), USD Million
   10.5.2.4. Market Size & Forecast, by End-User (2017-2025), USD Million
  10.5.3. Saudi Arabia
   10.5.3.1. Market Size & Forecast, by Product (2017-2025), USD Million
   10.5.3.2. Market Size & Forecast, by Disease (2017-2025), USD Million
   10.5.3.3. Market Size & Forecast, by Diagnostic Method (2017-2025), USD Million
   10.5.3.4. Market Size & Forecast, by End-User (2017-2025), USD Million
  10.5.4. Rest of MEA
   10.5.4.1. Market Size & Forecast, by Product (2017-2025), USD Million
   10.5.4.2. Market Size & Forecast, by Disease (2017-2025), USD Million
   10.5.4.3. Market Size & Forecast, by Diagnostic Method (2017-2025), USD Million
   10.5.4.4. Market Size & Forecast, by End-User (2017-2025), USD Million
11. Competitor Analysis
 11.1. Market Player Comparison
 11.2. Product-wise Player Mapping
 11.3. Region-wise Player Mapping
 11.4. Market Share Analysis
 11.5. Market Position Analysis
 11.6. Recent Development Analysis
12. Company Profiles
 12.1. F. Hoffmann-La Roche Ltd (Switzerland)
  12.1.1. Company Overview
  12.1.2. Company Financials
  12.1.3. Product Portfolio
  12.1.4. Recent Developments
 12.2. Abbott Laboratories (U.S.)
  12.2.1. Company Overview
  12.2.2. Company Financials
  12.2.3. Product Portfolio
  12.2.4. Recent Developments
 12.3. Siemens Healthineers (Germany)
  12.3.1. Company Overview
  12.3.2. Company Financials
  12.3.3. Product Portfolio
  12.3.4. Recent Developments
 12.4. Beckman Coulter (US)
  12.4.1. Company Overview
  12.4.2. Company Financials
  12.4.3. Product Portfolio
  12.4.4. Recent Developments
 12.5. Seramun Diagnostica GmbH (Germany)
  12.5.1. Company Overview
  12.5.2. Company Financials
  12.5.3. Product Portfolio
  12.5.4. Recent Developments
 12.6. SQI Diagnostics (Canada)
  12.6.1. Company Overview
  12.6.2. Company Financials
  12.6.3. Product Portfolio
  12.6.4. Recent Developments
 12.7. Thermo Fisher Scientific (U.S.)
  12.7.1. Company Overview
  12.7.2. Company Financials
  12.7.3. Product Portfolio
  12.7.4. Recent Developments
 12.8. Bio-Rad Laboratories (US)
  12.8.1. Company Overview
  12.8.2. Company Financials
  12.8.3. Product Portfolio
  12.8.4. Recent Developments
 12.9. Trinity Biotech (Ireland)
  12.9.1. Company Overview
  12.9.2. Company Financials
  12.9.3. Product Portfolio
  12.9.4. Recent Developments
 12.10. HTG Molecular Diagnostics (U.S.)
  12.10.1. Company Overview
  12.10.2. Company Financials
  12.10.3. Product Portfolio
  12.10.4. Recent Developments
 12.11. Oncimmune (UK)
  12.11.1. Company Overview
  12.11.2. Company Financials
  12.11.3. Product Portfolio
  12.11.4. Recent Developments
 12.12. Exagen Inc. (US)
  12.12.1. Company Overview
  12.12.2. Company Financials
  12.12.3. Product Portfolio
  12.12.4. Recent Developments
 12.13. AESKU GROUP GMBH & CO. KG (Germany)
  12.13.1. Company Overview
  12.13.2. Company Financials
  12.13.3. Product Portfolio
  12.13.4. Recent Developments
 12.14. ORGENTEC Diagnostika (Germany)
  12.14.1. Company Overview
  12.14.2. Company Financials
  12.14.3. Product Portfolio
  12.14.4. Recent Developments
 12.15. A. Menarini Diagnostics s.r.l (Italy)
  12.15.1. Company Overview
  12.15.2. Company Financials
  12.15.3. Product Portfolio
  12.15.4. Recent Developments
(Note: Financials are captured for public listed companies)

Key questions addressed by the research report-

  1. What are the current market trends and future market forecast from 2019 to 2025 for Autoimmune Disease Diagnostics market?
  2. What are the market dynamics and probable opportunities for market players during the forecast period?
  3. Initiatives undertaken my market players to address the COVID-19 impact to sustain in the competitive market.
  4. Which geographies have immense opportunities in different segments of the Autoimmune Disease Diagnostics market?
  5. What are the recent strategies adopted by market players such as product launch, partnership, agreement, collaboration, merger & acquisition, and geographical expansion?


    Have any question? Check your free sample before purchase or connect with our expert.

    Additional information

    Licensing Types

    , , ,

    Enquire about Autoimmune Disease Diagnostics Market Analysis by Product (Consumables, Assay Kits, Instruments), by Test Type (Inflammatory Markers, Routine Laboratory Tests), by Disease Type (Localized, Systemic Autoimmune Diseases), and by Region - Forecast to 2025